Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Insulin aspart/insulin detemir/insulin glargine abuse

Factitious hypoglycaemia: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Elmas ON, et al. Importance of insulin immunoassays in the diagnosis of factitious hypoglycemia. JCRPE Journal of Clinical Research in Pediatric Endocrinology 6: 258-261, No. 4, 2014. Available from: URL: http://doi.org/10.4274/jcrpe.1492 -Turkey Elmas ON, et al. Importance of insulin immunoassays in the diagnosis of factitious hypoglycemia. JCRPE Journal of Clinical Research in Pediatric Endocrinology 6: 258-261, No. 4, 2014. Available from: URL: http://​doi.​org/​10.​4274/​jcrpe.​1492 -Turkey
Metadaten
Titel
Insulin aspart/insulin detemir/insulin glargine abuse
Factitious hypoglycaemia: 2 case reports
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31601-x

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Tacrolimus

Case report

Warfarin